AUTM

AUTM

AUTM is a nonprofit association focused on technology transfer, intellectual property, and innovation management in the United States and internationally. It serves professionals who work at universities, research hospitals, government laboratories, and private research organizations, facilitating commercialization of academic research through licensing, patenting, startup formation, and collaboration. The organization interacts with a wide array of institutions and policy actors across North America, Europe, and Asia to influence practice and collect benchmarking data.

History

Formed in the early 1970s, AUTM traces roots to efforts at Stanford University, Massachusetts Institute of Technology, University of California, Berkeley, and Cornell University to manage inventions arising from federally funded research. The association grew alongside milestones such as the Bayh–Dole Act that reshaped technology transfer incentives for American institutions and paralleled developments at Johns Hopkins University and Columbia University in managing clinical and life sciences inventions. Over decades AUTM engaged with federal agencies like the National Institutes of Health, National Science Foundation, and Department of Defense as well as philanthropic funders such as the Gates Foundation and Howard Hughes Medical Institute. Its evolution reflects dialogues with research centers including Lawrence Berkeley National Laboratory, Argonne National Laboratory, and international partners such as University of Oxford and University of Tokyo.

Mission and Activities

AUTM's stated mission is to support technology transfer professionals at institutions like Harvard University, Yale University, Princeton University, and University of Michigan in moving discoveries to market. Activities include developing best practices used by offices at University of Pennsylvania, Duke University, University of Washington, UCLA, and University of Texas; issuing model policies referenced by legal teams at Sidley Austin, Jones Day, and Covington & Burling; and collaborating on policy positions with industry groups such as the Pharmaceutical Research and Manufacturers of America and trade associations like the American Intellectual Property Law Association. The organization convenes stakeholders from venture capital firms including Sequoia Capital, Andreessen Horowitz, and Kleiner Perkins as well as startup incubators like Y Combinator.

Membership and Governance

Membership comprises technology transfer officers, licensing managers, patent counsel, and entrepreneurship educators affiliated with institutions including Mayo Clinic, Cleveland Clinic, Memorial Sloan Kettering Cancer Center, and Mount Sinai Health System. Governance is overseen by a board drawn from member institutions such as Northwestern University, University of Chicago, Rice University, and University of Pittsburgh. Committees and regional groups coordinate with national consortia including Association of American Universities and international bodies like European Patent Office stakeholders. Leadership transitions have featured professionals who previously worked at entities such as GlaxoSmithKline, Pfizer, Merck & Co., and Eli Lilly.

Education and Professional Development

AUTM provides training and certification programs used by staff from Emory University, Vanderbilt University, Boston University, and University of Florida to build skills in licensing, negotiation, and entrepreneurship. It offers workshops referencing case law from the United States Court of Appeals for the Federal Circuit, patent practice influenced by the United States Patent and Trademark Office, and commercialization strategies relevant to the National Institutes of Health funding landscape. Courses are taught by instructors with backgrounds at IBM, Intel, Microsoft, and Google and often include guest speakers from startup ecosystems such as Silicon Valley, Cambridge, England, and Tel Aviv.

Annual Meetings and Events

AUTM's annual meeting attracts attendees from research organizations including Imperial College London, McGill University, University of Toronto, and University of Melbourne as well as corporate partners like Johnson & Johnson, Novartis, Roche, and Bayer. Regional conferences and workshops occur in collaboration with state and provincial associations such as California Life Sciences Association, Massachusetts Biotechnology Council, and Ontario Centres of Excellence. Events feature panels on licensing trends, technology acceleration programs with representatives from Small Business Administration-backed accelerators, and pitch sessions judged by investors from firms such as Benchmark, Bessemer Venture Partners, and Accel Partners.

Publications and Data Reporting

AUTM publishes benchmarking surveys and reports that draw on data from member offices at institutions like Ohio State University, University of Minnesota, University of North Carolina at Chapel Hill, and Michigan State University. Its annual licensing activity survey compiles metrics on disclosures, patents, licenses, and startups, and is cited by policymakers, university administrations, and economic development agencies including Brookings Institution and National Governors Association. AUTM also issues policy briefs and model agreements that reference legal frameworks such as the Patent Cooperation Treaty and standards from the World Intellectual Property Organization.

Impact and Criticism

Proponents credit AUTM with professionalizing technology transfer at institutions such as Texas A&M University, Purdue University, Virginia Tech, and University of Wisconsin–Madison and facilitating commercialization partnerships with corporations like Siemens, GE Healthcare, and Canon. Critics, including academics at Princeton University and advocates from organizations such as Public Knowledge and Knowledge Ecology International, argue that emphasis on patenting and licensing can impede open science and collaboration with nonprofit entities like Doctors Without Borders and Non-governmental Organization partners. Debates have engaged policymakers in the United States Congress and scholars at Harvard Law School and Stanford Law School over balancing university revenue, public access to inventions, and mission-aligned licensing.

Category:Technology transfer